Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Preoxygenation With High-flow Nasal Oxygen in Adult Trauma Patients During Rapid Sequence Induction Anaesthesia (PRIOR-Trauma)

22 de marzo de 2022 actualizado por: Malin Jonsson Fagerlund, Karolinska University Hospital

Preoxygenation With High-flow Nasal Oxygen in Comparison to Standard Face Mask in Adult Trauma Patients During Rapid Sequence Induction Anesthesia- a Prospective, Non-randomized, Before-and-after Study

Previous studies investigating apnoea oxygenation has shown that delivering oxygen via a high flow can maintain adequate oxygen saturation levels in a patient for over 30 minutes.

It has recently been demonstrated, in several studies, that High Flow Nasal Oxygen (HFNO) used during preoxygenation in patients undergoing emergency surgery is at least equally effective as preoxygenation with standard tight fitting mask. Data from these recent studies investigating arterial oxygen saturation levels during rapid sequence induction anaesthesia have not been able to detect any difference between the two methods. The mean apnea time among the patients in the previous studies have been relatively short.

Patients suffering traumatic injuries could be more prone to desaturate during prolonged apnea due to being hemodynamic unstable or suffering injuries to the respiratory tract.

Based on the above, the aim is now to conduct a trial where trauma patients are preoxygenated with high flow nasal oxygen before anaesthetised with rapid sequence induction (RSI) technique. The trial is set to be a before-and-after study. During approximately 6 to 9 months data will be registered from trauma patients undergoing emergency anaesthesia where preoxygenation is performed according to standard rutin, with traditional facemask. During the coming six to nine months trauma patients undergoing emergency anaesthesia will be preoxygenated with high flow nasal oxygen. Data will be registered and compared to the data collected from the patients preoxygenated with facemark.

The general purpose of this project is to compare the preoxygenation technique based on HFNO with traditional preoxygenation with a tight fitting mask, with the main focus being oxygen saturation levels, during rapid sequence induction (RSI) intubation in trauma patients in need of immediate anaesthesia.

Descripción general del estudio

Tipo de estudio

De observación

Inscripción (Anticipado)

300

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

Ubicaciones de estudio

      • Stockholm, Suecia, SE-17176
        • Reclutamiento
        • Karolinska University Hospital Solna
        • Contacto:

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años y mayores (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Método de muestreo

Muestra de probabilidad

Población de estudio

All eligable patients suffering Level 1 trauma and in need of emergency anaesthesia will be included.

Descripción

Inclusion Criteria:

  • 1 Adult, ≥18 years old
  • 2 Level 1 trauma with patients in need of emergency anaesthesia before leaving the trauma unit (trauma room or nearby operating theatre).

Exclusion Criteria:

  • 1 Patients with or with risk of skull or facial injuries where application of nasal cannula is decided to be avoided by the trauma team.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

Cohortes e Intervenciones

Grupo / Cohorte
Intervención / Tratamiento
Tight fitting facemask
Preoxygenation with tight facemask, 100% oxygen.
Preoxygenation with tight facemask, 10 L/min, 100% oxygen.
High flow nasal oxygen
Preoxygenation with high flow nasal oxygen, 100% oxygen
Preoxygenation with high flow nasal oxygen, 40-70 L/min, 100% oxygen.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Number of patients with a peripheral oxygen saturation (SpO2) below 93%
Periodo de tiempo: From start of anaesthesia until 1 minute after tracheal intubation.
Compare the number of patients with a peripheral oxygen saturation (SpO2) below 93% from induction of anesthesia (when induction drug is administered) until one minute after intubation between the group preoxygenated using HFNO and the group preoxygenated with traditional tight-fitting mask.
From start of anaesthesia until 1 minute after tracheal intubation.

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Lowest median SpO2.
Periodo de tiempo: From start of anaesthesia until 1 minute after tracheal intubation.
Lowest median SpO2 during preoxygenation using HFNO compared to traditional preoxygenation from when first anesthetic drug is administered until 1 minute after intubation
From start of anaesthesia until 1 minute after tracheal intubation.
End tidal gas levels
Periodo de tiempo: At the first breath after tracheal intubation.
Difference in levels of ETO2 and ETCO2 in the first breath after intubation with HFNO oxygenation compared to traditional pre-oxygenation.
At the first breath after tracheal intubation.
Time span from start of preoxygenation until intubation.
Periodo de tiempo: Could vary depending on patient and trauma, from a couple of minutes up to 20-30 minutes.
Compare the time span from start of preoxygenation until intubation between the HFNO group and the group with traditional preoxygenation.
Could vary depending on patient and trauma, from a couple of minutes up to 20-30 minutes.
Time span from entering trauma room until intubation.
Periodo de tiempo: Could vary depending on patient and trauma, from a couple of minutes up to an hour.
Time span from when the patient enters the trauma room until intubation in the HFNO group compared to the group with traditional preoxygenation.
Could vary depending on patient and trauma, from a couple of minutes up to an hour.
Difficulties with induction of anaesthesia
Periodo de tiempo: Could vary depending on patient and trauma, from a couple of minutes up to 20-30 minutes.
Compare the perceived difficulties during induction of anaesthesia between the HFNO technique and traditional preoxygenation, for example tolerance to mask or nasal cannula
Could vary depending on patient and trauma, from a couple of minutes up to 20-30 minutes.
Frequency of complications
Periodo de tiempo: Could vary depending on patient and trauma, from a couple of minutes up to 20-30 minutes.
Frequency of complications (aspiration, signs of intraabdominal/intracranial gas, difficulties intubating the trachea, hypotension) in the HFNO group compared to the group preoxygenated with traditional facemask.
Could vary depending on patient and trauma, from a couple of minutes up to 20-30 minutes.

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Malin Jonsson Fagerlund, Karolinska University Hospital and Karolinska Institute

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

1 de junio de 2021

Finalización primaria (Anticipado)

1 de enero de 2023

Finalización del estudio (Anticipado)

1 de enero de 2023

Fechas de registro del estudio

Enviado por primera vez

7 de junio de 2021

Primero enviado que cumplió con los criterios de control de calidad

10 de junio de 2021

Publicado por primera vez (Actual)

15 de junio de 2021

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

4 de abril de 2022

Última actualización enviada que cumplió con los criterios de control de calidad

22 de marzo de 2022

Última verificación

1 de marzo de 2022

Más información

Términos relacionados con este estudio

Términos MeSH relevantes adicionales

Otros números de identificación del estudio

  • PRIOR-Trauma

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

INDECISO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir